Captozyme
Gainesville
About Captozyme
Biotechnology company dedicated to helping people better manage their diets and overall health. The company plans to launch Nephure in the spring of 2017. With Nephure the company has created a product that allows people to enjoy the foods they love without the consequences of adding oxalate to their bodies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.4M
- Funding stage: M&A
- Last round: Series A (Mar 2017)
- Website: captozyme.com
- Phone: 785.760.3128
Industries & Categories
Biotechnology, Fitness, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/captozyme-101518 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.